|
Name |
stigmasta-7,22-diene-3β,5α,6α-triol
|
Molecular Formula | C29H48O3 | |
IUPAC Name* |
17-(5-ethyl-6-methylhept-3-en-2-yl)-10,13-dimethyl-1,2,3,4,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,5,6-triol
|
|
SMILES |
CCC(C=CC(C)C1CCC2C3=CC(O)C4(O)CC(O)CCC4(C)C3CCC21C)C(C)C
|
|
InChI |
InChI=1S/C29H48O3/c1-7-20(18(2)3)9-8-19(4)23-10-11-24-22-16-26(31)29(32)17-21(30)12-15-28(29,6)25(22)13-14-27(23,24)5/h8-9,16,18-21,23-26,30-32H,7,10-15,17H2,1-6H3/b9-8+/t19-,20+,21+,23-,24+,25+,26?,27-,28-,29+/m1/s1
|
|
InChIKey |
MNFRCFZQRZZFOY-CRRYCZBYSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 444.7 | ALogp: | 5.9 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 60.7 | Aromatic Rings: | 4 |
Heavy Atoms: | 32 | QED Weighted: | 0.457 |
Caco-2 Permeability: | -4.704 | MDCK Permeability: | 0.00002040 |
Pgp-inhibitor: | 0.035 | Pgp-substrate: | 0.014 |
Human Intestinal Absorption (HIA): | 0.062 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.304 |
Blood-Brain-Barrier Penetration (BBB): | 0.942 | Plasma Protein Binding (PPB): | 98.77% |
Volume Distribution (VD): | 1.119 | Fu: | 1.58% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.514 |
CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.906 |
CYP2C9-inhibitor: | 0.144 | CYP2C9-substrate: | 0.134 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.363 |
CYP3A4-inhibitor: | 0.601 | CYP3A4-substrate: | 0.773 |
Clearance (CL): | 16.98 | Half-life (T1/2): | 0.014 |
hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.006 |
Drug-inuced Liver Injury (DILI): | 0.02 | AMES Toxicity: | 0.033 |
Rat Oral Acute Toxicity: | 0.424 | Maximum Recommended Daily Dose: | 0.519 |
Skin Sensitization: | 0.009 | Carcinogencity: | 0.029 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.9 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001984 | 0.859 | D0G8OC | 0.415 | ||||
ENC004757 | 0.859 | D0G5CF | 0.397 | ||||
ENC004804 | 0.859 | D0Y7LD | 0.393 | ||||
ENC005438 | 0.859 | D06JPB | 0.380 | ||||
ENC006034 | 0.667 | D0N1TP | 0.374 | ||||
ENC003121 | 0.667 | D01QUS | 0.360 | ||||
ENC005238 | 0.650 | D08SVH | 0.341 | ||||
ENC004735 | 0.561 | D0M4WA | 0.320 | ||||
ENC001545 | 0.560 | D0G3SH | 0.312 | ||||
ENC005209 | 0.555 | D03ZTE | 0.312 |